tradingkey.logo
tradingkey.logo
Search

Immunome Inc

IMNM
Add to Watchlist
22.760USD
-0.320-1.39%
Close 07-31 16:00ETQuotes delayed by 15 min
2.58BMarket Cap
LossP/E TTM

IMNM Financials

See Immunome Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Immunome Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.48/-0.56
Revenue / Forecast
0.00/222.22K
Period
FY2025 Earnings
Revenue(YoY)
6.94M
-23.23%
EPS(YoY)
-2.43
51.33%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
9.25%-0.48
42.34%-0.74
16.50%-0.65
17.24%-0.50
79.13%-0.52
41.01%-1.28
-119.70%-0.78
-32.29%-0.60
-616.76%-2.51
-237.21%-2.16
---0.36
---0.46
---0.35
---0.64
----
----
----
----
----
----
Revenue
-100.00%0.00
-100.00%0.00
-100.00%0.00
69.84%4.01M
184.35%2.93M
-28.44%2.74M
-18.37%2.91M
-44.55%2.36M
-56.47%1.03M
--3.83M
--3.56M
--4.26M
--2.36M
----
----
----
----
----
----
----
Net Profit
-29.30%-53.84M
12.90%-69.90M
-21.99%-57.46M
-20.14%-43.40M
67.84%-41.64M
13.37%-80.25M
-984.00%-47.10M
-550.03%-36.12M
-2932.60%-129.49M
-1089.75%-92.63M
52.54%-4.34M
37.73%-5.56M
63.36%-4.27M
0.84%-7.79M
-18.59%-9.15M
-70.27%-8.92M
-198.95%-11.65M
-92.78%-7.85M
7.84%-7.72M
---5.24M
Net Margin
----
----
----
29.26%-1080.87%
88.69%-1423.10%
-21.05%-2930.93%
-1228.00%-1618.56%
-1072.19%-1528.00%
-6867.02%-12584.26%
---2421.17%
---121.88%
---130.35%
---180.63%
----
----
----
----
----
----
----
Gross Margin
----
----
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
----
----
----
----
----
----
----
Revenue
-100.00%0.00
-100.00%0.00
-100.00%0.00
69.84%4.01M
184.35%2.93M
-28.44%2.74M
-18.37%2.91M
-44.55%2.36M
-56.47%1.03M
--3.83M
--3.56M
--4.26M
--2.36M
----
----
----
----
----
----
----
Operating profit
-32.92%-59.33M
-13.06%-62.86M
-37.25%-60.14M
-37.93%-46.48M
-119.40%-44.64M
-301.40%-55.60M
-845.74%-43.82M
-483.70%-33.70M
-355.04%-20.34M
-77.87%-13.85M
45.71%-4.63M
35.32%-5.77M
61.64%-4.47M
0.73%-7.79M
-10.50%-8.53M
-55.51%-8.93M
-199.05%-11.65M
-92.59%-7.84M
-174.06%-7.72M
---5.74M
Net Profit
-29.30%-53.84M
12.90%-69.90M
-21.99%-57.46M
-20.14%-43.40M
67.84%-41.64M
13.37%-80.25M
-984.00%-47.10M
-550.03%-36.12M
-2932.60%-129.49M
-1089.75%-92.63M
52.54%-4.34M
37.73%-5.56M
63.36%-4.27M
0.84%-7.79M
-18.59%-9.15M
-70.27%-8.92M
-198.95%-11.65M
-92.78%-7.85M
7.84%-7.72M
---5.24M
Current assets
83.92%594.31M
198.54%660.78M
14.70%279.92M
-2.41%277.43M
3.13%323.13M
52.96%221.34M
166.96%244.04M
619.23%284.28M
573.30%313.33M
538.89%144.70M
212.64%91.41M
5.13%39.53M
0.50%46.54M
-60.01%22.65M
-52.22%29.24M
-40.14%37.60M
12.64%46.30M
32.04%56.64M
717.72%61.19M
516.38%62.81M
Total current liabilities
-10.99%27.41M
-17.16%44.99M
-20.45%31.45M
-42.66%22.88M
0.09%30.80M
148.78%54.31M
71.04%39.53M
51.18%39.90M
23.91%30.77M
197.76%21.83M
213.62%23.11M
206.24%26.39M
155.81%24.83M
-24.64%7.33M
-5.10%7.37M
144.76%8.62M
112.36%9.71M
220.21%9.73M
43.64%7.76M
26.25%3.52M
Total assets
80.86%619.79M
184.38%683.19M
16.54%299.38M
0.03%296.29M
7.17%342.69M
61.73%240.24M
175.76%256.90M
614.89%296.21M
564.58%319.75M
517.73%148.54M
204.99%93.16M
6.19%41.44M
0.81%48.11M
-58.49%24.05M
-51.17%30.55M
-39.17%39.02M
12.06%47.73M
30.10%57.92M
422.06%62.56M
425.14%64.14M
Total liabilities
-12.54%31.11M
-17.32%48.84M
-15.56%35.46M
-36.24%27.02M
4.05%35.57M
106.14%59.08M
-51.78%41.99M
32.03%42.38M
-0.20%34.18M
287.64%28.66M
1067.05%87.08M
267.16%32.10M
247.59%34.25M
-24.10%7.39M
-3.90%7.46M
148.07%8.74M
109.21%9.85M
206.29%9.74M
-38.85%7.76M
-24.25%3.52M
Total equity
91.68%588.69M
250.15%634.34M
22.81%263.92M
6.08%269.27M
7.55%307.13M
51.12%181.16M
3436.97%214.91M
2618.33%253.84M
1960.11%285.57M
619.88%119.88M
-73.68%6.08M
-69.16%9.34M
-63.40%13.86M
-65.44%16.65M
-57.87%23.08M
-50.05%30.28M
-0.02%37.87M
16.54%48.19M
7752.65%54.79M
701.60%60.62M
Net operating income
-10.52%-58.64M
-14.01%-47.95M
-18.56%-40.51M
-111.14%-49.40M
-374.98%-53.05M
-140.91%-42.06M
-296.64%-34.17M
-312.79%-23.40M
-146.21%-11.17M
-161.24%-17.46M
-13.78%-8.61M
29.68%-5.67M
479.12%24.17M
1.79%-6.68M
-82.65%-7.57M
-115.45%-8.06M
-80.37%-6.38M
-12.26%-6.80M
-63.96%-4.14M
---3.74M
Net investment
-336.12%-12.02M
-140.98%-4.00M
414.08%123.88M
21.44%-64.17M
113.67%5.09M
132.52%9.76M
67038.89%24.10M
-23925.88%-81.69M
-35023.58%-37.23M
-41569.44%-30.00M
---36.00K
-100.00%-340.00K
-1666.67%-106.00K
-414.29%-72.00K
100.00%0.00
-2025.00%-170.00K
80.65%-6.00K
69.57%-14.00K
79.03%-26.00K
---8.00K
Net financing
-100.08%-135.00K
2054.82%432.80M
14781.64%45.39M
-107.93%-55.00K
-26.07%162.23M
-63.81%20.09M
-99.50%305.00K
--694.00K
645326.47%219.44M
--55.50M
--60.88M
--0.00
6.25%34.00K
100.00%0.00
-100.00%0.00
-100.00%0.00
-57.89%32.00K
-100.50%-195.00K
248.85%585.00K
--27.30M

FAQs

What is the total revenue of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its total revenue reached 6.94M, with a year-on-year change of 9.04M.

What are the current assets of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its current assets were 660.78M, with a year-on-year change of 198.54.

What are the total assets of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its total assets of Immunome Inc were 683.19M, with a year-on-year change of 184.38.

What are the total liabilities of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its total liabilities of Immunome Inc were 48.84M, with a year-on-year change of -17.32.

What is the total equity of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its total equity of Immunome Inc was 634.34M, with a year-on-year change of 250.15.

What is the net operating income of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its net operating income of Immunome Inc was -214.11M, with a year-on-year change of -39.53.

What is the net investment of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its net investment of Immunome Inc was 60.80M, with a year-on-year change of 171.48.

What is the net financing of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its net financing of Immunome Inc was 640.36M, with a year-on-year change of 166.23.

What is the Earnings Per Share (EPS) of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.43, with a year-on-year change of 51.33.

What is the net income of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its net income was -212.39M, with a year-on-year change of 27.50.

What is the net margin of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its net profit margin was -3059.99, with a year-on-year change of 5.57.

What is the Return on Equity (ROE) of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its Return on Equity (ROE) was -52.09, with a year-on-year change of 73.24.

What is the Return on Assets (ROA) of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its Return on Assets (ROA) was -46.00, with a year-on-year change of 69.48.

What is the operating profit of Immunome Inc?

According to Immunome Inc's FY2025 earnings report, its operating profit was -214.11M, with a year-on-year change of -39.53.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.